December 1, 2022
On November 30, the Minnesota Department of Health (MDH) announced that it will add irritable bowel syndrome (IBS) and obsessive-compulsive disorder (OCD) to the list of qualifying medical conditions for participation in Minnesota’s Medical Cannabis Program.
The new qualifying conditions will take effect August 1, 2023.
No petitions for new delivery methods were considered this year. Petitions for gastroparesis and opioid use disorder were not approved.
As in past years, MDH conducted a formal petitioning process to solicit public input on potential qualifying medical conditions and delivery methods for medicine. Minnesotans submitted petitions in June and July. Following that, the process moved into a public comment period and a review panel. MDH staff prepared reports that summarized research pertaining to the use of medical cannabis for each proposed condition.
Click here to see the entire list of qualifying conditions.
October 9, 2025
The MMA is partnering with Hennepin Healthcare to offer an in-person session on “Supporting Patients, Families, and Professionals in the Aftermath of Crisis” on October 21 from 6 to 8 pm in Room RL110 at the HCMC Red Building, 730 South 8th Street, in Minneapolis.
October 9, 2025
The MMA, in partnership with the Wisconsin Medical Society, will lead a panel discussion titled "The Role of Medical and Professional Societies in Supporting Clinicians and Community Health" at the Transforming Community and Rural Healthcare 2025: Bold Innovation and Partnerships symposium, to be held on October 27-28, at the Mayo Civic Center in Rochester.
October 2, 2025
The federal government shutdown will affect the Minnesota healthcare system in several important ways.